Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Validation of the Bioequivalence of USP Potency Adjusted Porcine, Ovine, and Bovine Heparins

Nausheen Baig, Ahmed Kouta, Walter Jeske, PhD, Debra Hoppensteadt, PhD, Jeanine Walenga, PhD, Omer Iqbal, MD, Fakiha Siddiqui, Mamdouh Bakhos, MD, Jawed Fareed, PhD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-142861

Published: 2020

Journal Articles

Bovine Heparin Demonstrates the Same Interaction with HIT Antibodies As Porcine Heparin

Jeanine Walenga, PhD, Walter Jeske, PhD, Sabrina Bertini, Giulia Risi, Michelle Sung, BS, Ambar Farooqui, Cassie Bacher, Debra Hoppensteadt, PhD, Omer Iqbal, MD, Bruce Lewis, Mamdouh Bakhos, MD

Blood (2019) 134 (Supplement_1): 2351.

https://doi.org/10.1182/blood-2019-127304

Published: 2019

Journal Articles

Comparing a New Bovine Source Heparin to the Clinically Used Porcine Heparin for Platelet Function Effects and Heparin-Induced Thrombocytopenia Potential

Michelle Sung, BS, Jeanine Walenga, PhD, Walter Jeske, PhD, Omer Iqbal, MD, Mamdouh Bakhos, MD

Blood (2018) 132 (Supplement 1): 2540.

https://doi.org/10.1182/blood-2018-99-118781

Published: 2018

Journal Articles

Bovine Heparin Compared to Porcine Heparin to Demonstrate Bioequivalence

Marco Khiella, Walter Jeske, PhD, Jeanine Walenga, PhD, Omer Iqbal, MD, Rajan Laddu, Fakiha Siddiqui, Mamdouh Bakhos, MD

Blood (2018) 132 (Supplement 1): 1253.

https://doi.org/10.1182/blood-2018-99-118809

Published: 2018

Journal Articles

Down-Regulation of Protein C Pathway Associated with Increased Inflammation in Patients with Implanted Ventricular Assist Devices As a Potential Cause of Pump Thrombosis

Tania Torres, MS, BA, Jeanine M. Walenga, PhD, Walter Jeske, PhD, Vicki Escalante, BS, Erin Coglianese, MD, Jeffrey Schwartz, MD, Mamdouh Bakhos, MD

Blood (2016) 128 (22): 4995.

https://doi.org/10.1182/blood.V128.22.4995.4995

Published: 2016

Journal Articles

Identification & Characterization of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients with Continuous Flow Left Ventricular Assist Device Implants

Nathan McClane, Walter Jeske, PhD, Jeanine M. Walenga, PhD, Vicki Escalante, BS, Erin Coglianese, MD, Debra Hoppensteadt, PhD, Jeffrey Schwartz, MD, Mamdouh Bakhos, MD

Blood (2016) 128 (22): 4997.

https://doi.org/10.1182/blood.V128.22.4997.4997

Published: 2016

Journal Articles

Activated Immune Response in Ventricular Assist Device Implanted Patients Identified through a Platelet Activation Biomarker

Walter Jeske, PhD, Jeanine M. Walenga, PhD, Tania Torres, MS, BA, Vicki Escalante, BS, Jeffrey Schwartz, MD, Mamdouh Bakhos, MD

Blood (2016) 128 (22): 5001.

https://doi.org/10.1182/blood.V128.22.5001.5001

Published: 2016

Journal Articles

Neutralization Of Hemorrhage Induced By Direct Factor Xa and Thrombin Inhibitors In a Rat Model

Walter Jeske, PhD, Vicki Escalante, BS, Brian McGuire, BS, Jeanine M. Walenga, PhD, Jawed Fareed, Ph.D., Mamdouh Bakhos, MD

Blood (2013) 122 (21): 3644.

https://doi.org/10.1182/blood.V122.21.3644.3644

Published: 2013

Journal Articles

Assessment Of a Novel Synthetic Collagen Reagent By Platelet Aggregometry

Walter Jeske, PhD, Vicki Escalante, BS, Jeanine M. Walenga, PhD, Mamdouh Bakhos, MD

Blood (2013) 122 (21): 3645.

https://doi.org/10.1182/blood.V122.21.3645.3645

Published: 2013

Journal Articles

Left Ventricular Assist Device Induced Coagulation and Platelet Activation and the Effect of Current Anticoagulant Therapy Regimen

Alexander Service, Walter Jeske, PhD, Jeanine M. Walenga, PhD, Vicki Escalante, BS, Linda Dusek, Michael Ashbrook, MS, Jeffrey Schwartz, MD, Alain Heroux, MD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 48530.

https://doi.org/10.1182/blood.V120.21.48530.48530

Published: 2012

Journal Articles

Comparative Studies On Branded Enoxaparin and a US Generic Version of Enoxaparin.

Jeanine M. Walenga, PhD, Walter Jeske, PhD, Debra Hoppensteadt, Josephine Cunanan, MD, Vicki Escalante, BS, Hussein Khan, Joseph Bailey, Jawed Fareed, PhD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 2264.

https://doi.org/10.1182/blood.V120.21.2264.2264

Published: 2012

Journal Articles

Validation of the Use of Apixaban As an Alternate Anticoagulant for the Management of Patients with Heparin-Induced Thrombocytopenia.

Jeanine M. Walenga, PhD, Margaret Prechel, Debra Hoppensteadt, Vicki Escalante, BS, Talhah Chaudhry, Walter Jeske, PhD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 2265.

https://doi.org/10.1182/blood.V120.21.2265.2265

Published: 2012

Journal Articles

Comparative Antithrombotic and Bleeding Effects of Two U.S. Generic Enoxaparins

Walter Jeske, PhD, Jeanine M. Walenga, PhD, Vicki Escalante, BS, Debra Hoppensteadt, Josephine Cunanan, MD, Daniel Kahn, Anwar Akhras, Michelle Paulus, Jawed Fareed, PhD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 1172.

https://doi.org/10.1182/blood.V120.21.1172.1172

Published: 2012

Journal Articles

Left Ventricular Assist Device Induced Coagulation and Platelet Activation and the Effect of Current Anticoagulant Therapy Regimen

Alexander Service, Walter Jeske, PhD, Jeanine M. Walenga, PhD, Vicki Escalante, BS, Linda Dusek, Michael Ashbrook, MS, Jeffrey Schwartz, MD, Alain Heroux, MD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 5201.

https://doi.org/10.1182/blood.V120.21.5201.5201

Published: 2012

Journal Articles

Left Ventricular Assist Device Induced Coagulation and Platelet Activation and Effect of the Current Anticoagulant Therapy Regimen

Michael Ashbrook, MS, Jeffrey Schwartz, MD, Alain Heroux, MD, Vicki Escalante, BS, Walter Jeske, PhD, Jeanine M. Walenga, PhD, Mamdouh Bakhos, MD

Blood (2011) 118 (21): 2271.

https://doi.org/10.1182/blood.V118.21.2271.2271

Published: 2011

NARROW

Validation of the Bioequivalence of USP Potency Adjusted Porcine, Ovine, and Bovine Heparins

Bovine Heparin Demonstrates the Same Interaction with HIT Antibodies As Porcine Heparin

Comparing a New Bovine Source Heparin to the Clinically Used Porcine Heparin for Platelet Function Effects and Heparin-Induced Thrombocytopenia Potential

Bovine Heparin Compared to Porcine Heparin to Demonstrate Bioequivalence

Down-Regulation of Protein C Pathway Associated with Increased Inflammation in Patients with Implanted Ventricular Assist Devices As a Potential Cause of Pump Thrombosis

Identification & Characterization of Novel Hemostatic Biomarkers of Adverse Clinical Events in Patients with Continuous Flow Left Ventricular Assist Device Implants

Activated Immune Response in Ventricular Assist Device Implanted Patients Identified through a Platelet Activation Biomarker

Neutralization Of Hemorrhage Induced By Direct Factor Xa and Thrombin Inhibitors In a Rat Model

Assessment Of a Novel Synthetic Collagen Reagent By Platelet Aggregometry

Left Ventricular Assist Device Induced Coagulation and Platelet Activation and the Effect of Current Anticoagulant Therapy Regimen

Comparative Studies On Branded Enoxaparin and a US Generic Version of Enoxaparin.

Validation of the Use of Apixaban As an Alternate Anticoagulant for the Management of Patients with Heparin-Induced Thrombocytopenia.

Comparative Antithrombotic and Bleeding Effects of Two U.S. Generic Enoxaparins

Left Ventricular Assist Device Induced Coagulation and Platelet Activation and the Effect of Current Anticoagulant Therapy Regimen

Left Ventricular Assist Device Induced Coagulation and Platelet Activation and Effect of the Current Anticoagulant Therapy Regimen

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only